
Agnieszka Boesen
Examiner (ID: 5487, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1648, 1672 |
| Total Applications | 1076 |
| Issued Applications | 632 |
| Pending Applications | 101 |
| Abandoned Applications | 361 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18694001
[patent_doc_number] => 20230324404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/999192
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999192 | METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES | May 18, 2021 | Abandoned |
Array
(
[id] => 18559958
[patent_doc_number] => 11725194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Hepatitis B virus (HBV) vaccines and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/324494
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 35346
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324494 | Hepatitis B virus (HBV) vaccines and uses thereof | May 18, 2021 | Issued |
Array
(
[id] => 17065889
[patent_doc_number] => 20210268104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)
[patent_app_type] => utility
[patent_app_number] => 17/323082
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323082 | Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV) | May 17, 2021 | Abandoned |
Array
(
[id] => 19235010
[patent_doc_number] => 20240192204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => A DEVICE AND ASSAYS FOR DETECTION OF PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/998556
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998556 | A DEVICE AND ASSAYS FOR DETECTION OF PATHOGENS | May 16, 2021 | Pending |
Array
(
[id] => 19275499
[patent_doc_number] => 12025622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Use and treatment of di-amino acid repeat-containing proteins associated with ALS
[patent_app_type] => utility
[patent_app_number] => 17/322604
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 42
[patent_no_of_words] => 23202
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322604 | Use and treatment of di-amino acid repeat-containing proteins associated with ALS | May 16, 2021 | Issued |
Array
(
[id] => 17482265
[patent_doc_number] => 20220089769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/320046
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320046 | REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES | May 12, 2021 | Abandoned |
Array
(
[id] => 17228614
[patent_doc_number] => 20210355170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Stabilizing Mutants of Prefusion Sars-Cov-2 (Covid-19) Spike Protein And Improved Yeast Surface Display Engineering Platform For The Same
[patent_app_type] => utility
[patent_app_number] => 17/318719
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318719 | Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same | May 11, 2021 | Issued |
Array
(
[id] => 17052193
[patent_doc_number] => 20210261627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/316834
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316834 | Respiratory syncytial virus (RSV) vaccine | May 10, 2021 | Issued |
Array
(
[id] => 17185561
[patent_doc_number] => 20210332446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/240858
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240858 | ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS | Apr 25, 2021 | Abandoned |
Array
(
[id] => 19827178
[patent_doc_number] => 12247950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Virus detection system, virus detection method, and virus detection program
[patent_app_type] => utility
[patent_app_number] => 17/236516
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 6331
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236516 | Virus detection system, virus detection method, and virus detection program | Apr 20, 2021 | Issued |
Array
(
[id] => 17343982
[patent_doc_number] => 20220010313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/234145
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234145 | CRISPR/CAS-related methods and compositions for treating herpes simplex virus | Apr 18, 2021 | Issued |
Array
(
[id] => 18437470
[patent_doc_number] => 20230184765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => DETECTION ASSAYS FOR CORONAVIRUS NEUTRALIZING ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/919133
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -178
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919133 | Detection assays for coronavirus neutralizing antibodies | Apr 18, 2021 | Issued |
Array
(
[id] => 17823750
[patent_doc_number] => 11428694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
[patent_app_type] => utility
[patent_app_number] => 17/231782
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 41571
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231782 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | Apr 14, 2021 | Issued |
Array
(
[id] => 18597572
[patent_doc_number] => 20230272368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/919100
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919100 | PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID | Apr 13, 2021 | Abandoned |
Array
(
[id] => 19332893
[patent_doc_number] => 20240247323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => MULTIPLEXED PCR ASSAY WITH POINT OF CARE SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/918802
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918802 | MULTIPLEXED PCR ASSAY WITH POINT OF CARE SAMPLE | Apr 12, 2021 | Pending |
Array
(
[id] => 20848747
[patent_doc_number] => 12685764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Universal influenza vaccine using nucleoside-modified mRNA
[patent_app_type] => utility
[patent_app_number] => 17/995207
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 97
[patent_no_of_words] => 55642
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995207 | Universal Influenza Vaccine Using Nucleoside-Modified mRNA | Mar 30, 2021 | Issued |
Array
(
[id] => 20716387
[patent_doc_number] => 12631629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-19
[patent_title] => Device and methods for rapid detection of target analytes in a biological sample
[patent_app_type] => utility
[patent_app_number] => 17/907109
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 34
[patent_no_of_words] => 14692
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907109 | Device and methods for rapid detection of target analytes in a biological sample | Mar 30, 2021 | Issued |
Array
(
[id] => 18675701
[patent_doc_number] => 20230313323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => ASSAYS FOR DETECTING CORONAVIRUS DISEASE 2019 (COVID-19)
[patent_app_type] => utility
[patent_app_number] => 17/906542
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906542 | ASSAYS FOR DETECTING CORONAVIRUS DISEASE 2019 (COVID-19) | Mar 25, 2021 | Pending |
Array
(
[id] => 18470282
[patent_doc_number] => 20230204567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHOD FOR DETERMINING THE POTENCY OF ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/999131
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999131 | METHOD FOR DETERMINING THE POTENCY OF ANTIGENS | Mar 18, 2021 | Abandoned |
Array
(
[id] => 17141954
[patent_doc_number] => 20210309966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHODS OF IMPROVING VECTOR TRANSDUCTION EFFICIENCY INTO T LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/200745
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200745 | Methods of improving vector transduction efficiency into T lymphocytes | Mar 11, 2021 | Issued |